NASDAQ: KOD

Kodiak Sciences Inc.

Healthcare | Biotechnology

No licensed closing price on file for KOD. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

Kodiak Sciences Inc. (NASDAQ: KOD) is a biotechnology company. Figures from SEC EDGAR; updated 2026-10-21 18:02 UTC.

What Kodiak Sciences Inc. does

Kodiak Sciences, founded in 2009, develops medicines for retinal diseases using its proprietary Antibody Biopolymer Conjugate (ABC) platform technology. The company's lead program, tarcocimab, is an anti-VEGF therapy designed to work longer in the eye than existing treatments and has completed four Phase 3 studies in diabetic retinopathy, retinal vein occlusion, and wet age-related macular degeneration.

Summarized from Kodiak Sciences Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Key facts

Charts

Charts are in the appInteractive charts for KOD are available in Oxford Ledge.
Open KOD in Oxford Ledge →

SEC Filings

SEC EDGAR ↗

Recent Insider Activity (last 90 days)

Source: SEC EDGAR · Filed 2026-09-30

2026-09-30DirectorPurchase61,700$4.71M
2026-09-30DirectorPurchase49,771$3.91M
2026-09-30DirectorPurchase619$52.1K

Top Institutional Holders (latest 13F)

Source: SEC EDGAR · As of 2026-Q2

BAKER BROS. ADVISORS LP19,919,186$776.05M0.0%
BlackRock, Inc.4,135,355$161.11M+5.1%
PRICE T ROWE ASSOCIATES INC /MD/3,248,611$126.57M+59.3%

View QoQ ownership changes →Full institutional ownership →

Recent 8-K Events (parsed from SEC filings)All events →

Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

2019-02-05Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →

Company news

View all →

Kodiak Sciences Inc. (KOD) Presents at American Academy of Ophthalmology Conference 2026 - Slideshow
Seeking Alpha Feed2026-10-10
Kodiak Sciences' Two Wet AMD Treatments Match Aflibercept in Phase III Study
marketbeat.com2026-10-02
Kodiak Sciences More Than Doubles on Eye Disease Trial Results
Yahoo2026-10-01
Stocks making the biggest moves midday: MongoDB, Boeing, Kodiak Sciences, Roblox, Nvidia & more
CNBC Top News2026-09-28
Kodiak Sciences Inc. (KOD) Discusses DAYBREAK Topline Data and Primary Endpoint Results Transcript
seekingalpha.com2026-09-28

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for KOD and 5,000+ tickers.

Create a free account — keep KOD

For your agent

GET /api/data?ticker=KOD

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt